Cite
HARVARD Citation
Perez, E. et al. (2016). Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results. Breast cancer research. 18 (1), pp. 1-13. [Online].